TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 91 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $124 | -49.6% | 3,285 | -49.4% | 0.00% | – |
| Q2 2023 | $246 | +192.9% | 6,494 | +89.0% | 0.00% | – |
| Q1 2023 | $84 | -16.0% | 3,436 | 0.0% | 0.00% | – |
| Q4 2022 | $100 | -99.9% | 3,436 | 0.0% | 0.00% | – |
| Q3 2022 | $103,000 | -16.9% | 3,436 | 0.0% | 0.00% | – |
| Q2 2022 | $124,000 | -16.8% | 3,436 | 0.0% | 0.00% | – |
| Q1 2022 | $149,000 | -13.4% | 3,436 | 0.0% | 0.00% | – |
| Q4 2021 | $172,000 | -21.5% | 3,436 | 0.0% | 0.00% | – |
| Q3 2021 | $219,000 | -11.3% | 3,436 | 0.0% | 0.00% | – |
| Q2 2021 | $247,000 | -2.4% | 3,436 | 0.0% | 0.00% | – |
| Q1 2021 | $253,000 | +0.4% | 3,436 | 0.0% | 0.00% | – |
| Q4 2020 | $252,000 | +34.0% | 3,436 | 0.0% | 0.00% | – |
| Q3 2020 | $188,000 | -17.5% | 3,436 | 0.0% | 0.00% | – |
| Q2 2020 | $228,000 | +128.0% | 3,436 | +110.7% | 0.00% | – |
| Q1 2020 | $100,000 | -30.1% | 1,631 | 0.0% | 0.00% | – |
| Q4 2019 | $143,000 | -31.9% | 1,631 | -41.3% | 0.00% | – |
| Q3 2019 | $210,000 | -11.4% | 2,780 | 0.0% | 0.00% | – |
| Q2 2019 | $237,000 | -21.0% | 2,780 | 0.0% | 0.00% | – |
| Q1 2019 | $300,000 | +89.9% | 2,780 | +49.0% | 0.00% | – |
| Q4 2018 | $158,000 | -13.7% | 1,866 | 0.0% | 0.00% | – |
| Q3 2018 | $183,000 | -15.3% | 1,866 | 0.0% | 0.00% | – |
| Q2 2018 | $216,000 | -96.2% | 1,866 | -96.5% | 0.00% | -100.0% |
| Q4 2016 | $5,635,000 | -18.7% | 53,527 | -14.7% | 0.01% | -20.0% |
| Q3 2016 | $6,933,000 | +12.1% | 62,735 | +47.8% | 0.01% | +11.1% |
| Q2 2016 | $6,182,000 | +1.6% | 42,456 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $6,082,000 | +43.5% | 42,456 | +54.8% | 0.01% | +28.6% |
| Q4 2015 | $4,239,000 | +8.2% | 27,426 | 0.0% | 0.01% | +16.7% |
| Q3 2015 | $3,919,000 | -0.6% | 27,426 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $3,941,000 | -52.9% | 27,426 | -53.8% | 0.01% | -50.0% |
| Q1 2015 | $8,376,000 | +9.2% | 59,391 | +14.8% | 0.01% | +9.1% |
| Q4 2014 | $7,667,000 | +141.7% | 51,736 | +150.9% | 0.01% | +120.0% |
| Q3 2014 | $3,172,000 | +130.5% | 20,618 | +110.2% | 0.01% | +150.0% |
| Q2 2014 | $1,376,000 | +178.0% | 9,809 | +119.8% | 0.00% | +100.0% |
| Q1 2014 | $495,000 | +12.2% | 4,463 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $441,000 | +30.1% | 4,463 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $339,000 | +36.1% | 4,463 | 0.0% | 0.00% | – |
| Q2 2013 | $249,000 | – | 4,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
| FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
| Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
| Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
| Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
| Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
| RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
| MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |